Elon Musk's brain-computer interface (BCI) company Neuralink has been given the green light to test its device in tetraplegic patients in Canada – the first international trial of the technology.

We preselected all newsletters you had before unsubscribing.

Brain computer interface (BCI) company Neuralink has been given regulatory approval to start a new trial of its implant to see if it can be used to control a robotic arm. If it proves to be ...

In January 2024, Elon Musk's neurotechnology company, Neuralink, conducted their first human trial. The first-ever patient was a 29-year-old man named Noland Arbaugh, who had been paralyzed.

DiveWire guarantees visibility for your news announcements through instant distribution to HR Dive’s audience and its 240,000 newsletter subscribers for 21 days.